H19, Rb-E2F1, and CDK-beta-catenin in colorectal cancer (WP3969)

Homo sapiens

In this proposed model, H19 interacts with macroH2A, and this may consequently lead to de-repression of genes including CDK8, CDK4, and CCND1. Increased CDK4-cyclin D1 complex phosphorylates Rb to disrupt Rb-E2F1 interaction, leading to E2F1 activation. The increase of CDK8 expression enhances the function of mediator complex including MED1, and facilitates the gene regulation by beta-catenin. These downstream targets could work in a synergistic way of promoting cell proliferation and increasing cell motility in colorectal cancer. Reference: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264449/ Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP3969 CPTAC Assay Portal]

Authors

Kristina Hanspers , Alex Pico , Egon Willighagen , Martina Summer-Kutmon , and Eric Weitz

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

CPTAC ExRNA

Annotations

Pathway Ontology

signaling pathway

Disease Ontology

colorectal cancer

Participants

Label Type Compact URI Comment
macroH2A GeneProduct ensembl:ENSG00000113648
CDK4 GeneProduct ensembl:ENSG00000135446
CTNNB1 GeneProduct ensembl:ENSG00000168036
CCND1 GeneProduct ensembl:ENSG00000110092
E2F1 GeneProduct ensembl:ENSG00000101412
CDK8 GeneProduct ensembl:ENSG00000132964
MED1 GeneProduct ensembl:ENSG00000125686
CSRP2 GeneProduct ensembl:ENSG00000175183
JAG1 GeneProduct ensembl:ENSG00000101384
SOX4 GeneProduct ensembl:ENSG00000124766
CDH1 GeneProduct ensembl:ENSG00000039068
TULP3 GeneProduct ensembl:ENSG00000078246
PMAIP1 GeneProduct ensembl:ENSG00000141682
RB1 GeneProduct ensembl:ENSG00000139687

References

  1. H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer. Ohtsuka M, Ling H, Ivan C, Pichler M, Matsushita D, Goblirsch M, et al. EBioMedicine. 2016 Nov;13:113–24. PubMed Europe PMC Scholia